Phenotypic Detection of Carbapenemase and AmpC-β-Lactamase Production among Extended Spectrum β-Lactamase (ESBL)-Producing Escherichia coli and Klebsiella spp. Isolated from Clinical Specimens
Zakaria Garba(Université Joseph Ki-Zerbo), Anu Kantele(Helsinki University Hospital), Nicolas Barro(Université Joseph Ki-Zerbo), Hamtandi Magloire Natama(Research Institute of Health Sciences), Isidore Juste O. Bonkoungou(Université Joseph Ki-Zerbo), Bérenger Kaboré(Institut de Recherche en Sciences de la Santé), Kaisa Haukka(University of Helsinki), Toussaint Rouamba(Institut de Recherche en Sciences de la Santé), Halidou Tinto(Institut de Recherche en Sciences de la Santé), Lassana Sangaré(Université Joseph Ki-Zerbo), Juha Kirveskari(University of Helsinki)
Cited by 13
Related Papers
Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial
|The Lancet|2021|457
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine
|New England Journal of Medicine|2015|451
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial
|The Lancet|2024|345
Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial
|The Lancet Infectious Diseases|2022|285
Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19
|Cell Reports Medicine|2020|209